Prosecution Insights
Last updated: April 19, 2026

Mbrace Therapeutics Inc.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19050987 Antibody-Drug Conjugates Against the Glucose-regulating Protein 78 (GRP78) ESSEX, LAURA ANN 1675 Final Rejection Feb 11, 2025

Managing Mbrace Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month